Diabetes

Nurse and patient in hospital bed with medical monitors

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading clinics across Germany to translate research findings directly and purposefully into new therapeutic approaches — and,…

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

The journal Metabolism honors Dr. Anja Schork, who works at the Institute for Diabetes Research and Metabolic Diseases at Helmholtz Munich at the University of Tübingen and at the German Center for Diabetes Research (DZD), with the Junior Faculty…

231219-095510 - MK1_7810 - marcelkatz.de_Retusche_16zu9_4K

Sugar can be enjoyable, but it can also make you ill. How much sugar is still healthy? And are sweeteners really a good alternative? Eckart von Hirschhausen addresses these questions in his new ARD documentary “Hirschhausen und der Zucker”…

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

Cardiovascular diseases are the leading cause of death worldwide, and lowering blood lipids is a central strategy to reduce risk. Bempedoic acid, a recently approved cholesterol-lowering drug, has now been shown by researchers at Helmholtz Munich to…

Diabetes

News

Translation: Where Medical Research Reaches People

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults

Anja Schork Receives “Junior Faculty Award 2025”

IDM Researchers Accompany Hirschhausen Documentary “Hirschhausen and the Sugar”

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

Cholesterol-Lowering Drug Found to Target Key Metabolic Switch

Press Contact